Xoma reported $477.1M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Agenus USD 107M 16M Dec/2025
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
BioMarin Pharmaceutical USD 10.57B 290M May/2026
Celldex Therapeutics USD 2.17B 361M May/2026
Curis USD 4M 9M May/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Emergent BioSolutions USD 125M 51M Dec/2023
Incyte USD 21.73B 3B May/2026
MacroGenics USD 102M 4M Dec/2025
Novartis USD 232.75B 75B May/2026
Pfizer USD 148.08B 6.51B May/2026
Prothena USD 514M 11M Dec/2025
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026